This is supported by the fact that not only intracerebroventricular administration of Igf1 improves outcome after stroke, but even systemic injections of Igf1 are effective (Rizk et al., 2007; Fletcher et al., 2009; Chang et al., 2010). This evidence concerns the gene IGF1 and Stroke.